Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

66.99
BATS BZX Real-Time Price
As of 10:16am ET
 -0.52 / -0.76%
Today’s Change
65.38
Today|||52-Week Range
103.10
-6.46%
Year-to-Date

Today’s Trading

Previous close67.50
Today’s open67.39
Day’s range66.94 - 67.45
Volume78,069
Average volume (3 months)10,035,482
Market cap$88.2B
Dividend yield3.11%
Data as of 10:16am ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-28.90%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-5.37%
P/E ratio6.8
Price/Sales3.21
Price/Book4.68

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen-1.58-0.57%
AMGNAmgen-0.37-0.22%
ILMNIllumina Inc-0.96-0.56%
BIVVBioverativ Inc+0.93+1.83%
Data as of 10:16am ET, 03/28/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$2.26
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts


Search for Jobs